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LETTER TO THE EDITOR
INTRODUCTION AND TRANSMISSION OF ZIKA VIRUS IN BRAZIL:  
NEW CHALLENGES FOR THE AMERICAS
Campinas, August 27, 2015
Dear Editor
In October 2014 an outbreak of a febrile rash illness of unknown 
etiology was identified in the State of Rio Grande do Norte, Northeastern 
Brazil, whose clinical manifestations were low fever or no fever, 
maculopapular rash, pruritus, arthralgia, and limb edema, lasting 4-7 
days. In the following months, similar cases were identified in other 
States of the region. The initial diagnostic hypotheses of dengue, measles, 
rubella, enterovirus, and other arbovirus (including Chikungunya) were 
not confirmed. In early May 2015, Zika virus (ZIKV), an arbovirus which 
until then had not circulated in Brazil, was confirmed by RT-PCR tests in 
15 of 45 samples from patients of two States: Bahia and Rio Grande do 
Norte. CAMPOS et al. (2015) reported seven confirmed cases of 24 tested 
samples and ZANLUCA et al. (2015) confirmed eight cases of 21 acute 
phase serum samples1,2. In the following weeks, since the end of May, 
new autochthonous cases were laboratory confirmed in other States of the 
Northeastern region (Alagoas, Ceará, Maranhão, Paraíba, Pernambuco, 
Piauí), Northern region (Pará, Roraima) Southeastern region (São Paulo 
and Rio de Janeiro), and Southern region (Paraná), showing that the 
disease has already expanded throughout the Brazilian territory. These 
results represent not only the first human cases in Brazil, but also the first 
presumptive vector borne transmission of ZIKV in Continental America 
and, potentially, the epidemiological trigger for a worldwide epidemic. 
Previously imported cases of flavivirus infection have been identified in 
Europe3, and recently, a first “exported” case of ZIKV to Europe was 
reported in the new Brazilian scenario of ZIKV expansion4. 
ZIKV infection was confirmed in different Brazilian States in a short 
period of time; some locations were separated by 2300 km away5 ZIKV 
circulation has occurred simultaneously to a dengue epidemic of large 
proportions in regions dense and chronically infested by Aedes aegypti. 
The confirmed circulation of Chikungunya virus in some regions of the 
Brazilian territory, as in other countries of South America and Caribe 
raises concerns about the implications of the new virus and its co-
circulation with other arboviruses in the context of public health. 
The ZIKV is an arbovirus of the genus Flavivirus belonging to the 
Flaviviridae family. It was first identified in 1947 in a rhesus monkey 
sentinel for yellow fever research conducted at the Zika forest in 
Uganda6,7. The disease in humans has been well documented only from 
the 1960’s, and by 2007, when less than 20 laboratory confirmed cases 
were described8. The ZIKV has been isolated from various species of 
Aedes mosquitos especially Ae. africanus, Ae. aegypti and Ae. albopictus, 
all potential vectors. Recent epidemics transmission has been attributed 
to Ae. hensilli and Ae. Polynesiensis9,10. The sylvatic cycle of viruses is 
maintained by genus Aedes mosquitoes and non-human primates8 and, 
until recently human beings would be considered only casual hosts.
The geographical expansion of ZIKV transmission beyond Asia and 
Africa has possibly occurred after 2007, when an outbreak hit the Island 
of Yap, Micronesia, with an estimated infection of 73% of the population 
and 12% with clinical manifestations11. Since then a spread of the virus 
to several Pacific islands has been observed, with autochthonous cases 
reported in New Caledonia, Cook Islands and Easter Island10,11. 
Special attention should be given to an outbreak in French 
Polynesia from October 2013 until early 2014 due to a large number 
of symptomatic patients (more than 29,000 people, or about 10% of 
the population) and the severe cases, particularly with neurological 
disorders (including 40 cases of Guillain-Barré syndrome (GBS) and 72 
cases of various neurological syndromes), assigned to infection ZIKV10. 
However, it is noteworthy that a real causal relationship between ZIKV 
as the etiologic agent of neurological complications (especially those 
related to immune mechanisms) or neurological conditions resulting 
from potential association between ZIKV co-circulation and distinct 
virus serotypes Dengue (serotypes 1 and 3)11 has not yet been well 
established. 
The laboratory diagnosis of the ZIKV infection might require the 
identification by direct methods, such as viral isolation and RT-PCR since 
there is no serological testing available for specific IgM/IgG antibodies to 
ZIKV6. There are also specific limitations of serological studies resulting 
from the possible cross-reactivity with other flaviviruses, among which 
the dengue virus and yellow fever virus (wild and vaccine virus). This 
is a very probable scenario in South America and other regions of the 
world, where there is an endemic circulation of other pathogens like 
Japanese encephalitis virus and West Nile virus.
Transmission of Zika virus in Brazil has many concerns: social and 
ecological context in the Americas, particularly in Brazil favors the spread 
of arboviruses and the occurrence of severe cases associated with viral 
co-circulation; the current strategy to combat the vector in most areas 
seems ineffective; climate and environmental conditions are adequate 
to the vector activity; crowded cities with intense flow of travelers from 
around the world makes Brazil not only vulnerable to large outbreaks 
but also a point of dispersion of cases through the world. Moreover, the 
widespread presence of Ae. albopictus in the Americas brings concern that 
the vector becomes a ZIKV very efficient transmitter, further aggravating 
this complex epidemiological context. Nowadays, the high vector density 
in Brazil supports the simultaneous circulation of three arboviruses 
transmitted by Ae. aegypti: dengue, Chikungunyia and Zika. However, 
this context shows that there is also risk of a potential introduction and/
or expansion of other arboviruses, in not endemic areas in the Americas. 
The recent introduction of ZIKV raises many concerns to the Brazilian 
health authorities especially about the potential occurrence of severe 
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cases in the future. However, the recent report of a high number of cases 
presenting neurological syndromes, mostly compatible with GBS, in 
some Northeastern Brazilian States, has already brought a worrying 
impact on the health system, despite the fact that further epidemiological 
information are awaited from ongoing investigation5.
From this, questions as how to structure patient care to address 
difficulties on clinical and laboratory diagnosis and what will be the 
implications of co-circulation of ZIKV and other flaviviruses are only 
some of the too many questions to be answered. The apparent rapid 
expansion of ZIKV transmission area in Brazil should now be seen as 
an emergent public health challenge not only to the country, but to the 
Americas and, to some degree, also to the globe.
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